BACTERIAL VAGINOSIS
Clinical trials for BACTERIAL VAGINOSIS explained in plain language.
Never miss a new study
Get alerted when new BACTERIAL VAGINOSIS trials appear
Sign up with your email to follow new studies for BACTERIAL VAGINOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to halt recurring vaginal infection
Prevention Not yet recruitingThis study tests whether adding BPR-101 capsules to standard antibiotic treatment (metronidazole) can prevent bacterial vaginosis (BV) from returning. About 80 women with BV will receive either the combination or a placebo. The goal is to see if the new approach lowers the chance…
Matched conditions: BACTERIAL VAGINOSIS
Phase: PHASE2 • Sponsor: Chengdu Syncor Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated May 01, 2026 16:01 UTC
-
Probiotic breakthrough: new study aims to stop recurrent vaginal infections without antibiotics
Prevention Not yet recruitingThis study tests whether taking a daily probiotic pill containing a specific friendly bacteria (Lactobacillus gasseri) can prevent bacterial vaginosis (BV) from returning after standard antibiotic treatment. BV is a common vaginal infection that often comes back, causing discomfo…
Matched conditions: BACTERIAL VAGINOSIS
Phase: PHASE2, PHASE3 • Sponsor: Kaneka Americas Holding Inc. • Aim: Prevention
Last updated May 01, 2026 16:01 UTC
-
New bacterial vaginosis drug begins first human safety tests
Symptom relief Not yet recruitingThis early-stage trial tests the safety and tolerability of a new drug called GenSci142 for bacterial vaginosis. It involves 30 healthy Chinese women who will receive either the drug or a placebo. The main goal is to check for side effects and how the drug moves through the body.
Matched conditions: BACTERIAL VAGINOSIS
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC